Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 438 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
ALX Oncology Holdings Inc.
Market Cap
$162.82M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$153.84M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-91.83%
Market Cap
$172.99M
Operating Margin
0.00%
TTM Avg
-3330.88%
3Y Avg
-1665.44%
5Y Avg
-1110.29%
Market Cap
$173.04M
Operating Margin
-425.72%
TTM Avg
-233.78%
3Y Avg
-167.06%
5Y Avg
-119.37%
Market Cap
$152.45M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$152.16M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-8182.07%
Market Cap
$174.17M
Operating Margin
-152.19%
TTM Avg
-95.13%
3Y Avg
-132.07%
5Y Avg
-169.10%
Market Cap
$149.51M
Operating Margin
-54.46%
TTM Avg
-76.53%
3Y Avg
-68.82%
5Y Avg
-55.26%
Market Cap
$176.96M
Operating Margin
-96.56%
TTM Avg
-271.71%
3Y Avg
-1442.10%
5Y Avg
-1248.16%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $162.82M | 0.00% | 0.00% | 0.00% | 0.00% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 0.00% | 0.00% | 0.00% | -91.83% |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | 0.00% | -3330.88% | -1665.44% | -1110.29% |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | -425.72% | -233.78% | -167.06% | -119.37% |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 0.00% | 0.00% | 0.00% | -8182.07% |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | -152.19% | -95.13% | -132.07% | -169.10% |
| Codexis, Inc. (CDXS)vs › | $149.51M | -54.46% | -76.53% | -68.82% | -55.26% |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | -96.56% | -271.71% | -1442.10% | -1248.16% |
| Immuneering Corporation (IMRX)vs › | $146.66M | 0.00% | 0.00% | -4081.44% | -3115.66% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | -2046.87% |
| 2020-03-31 | -800.31% |
| 2019-12-31 | -637.51% |
| 2019-09-30 | -241.56% |
| 2019-06-30 | -323.47% |
| 2019-03-31 | -409.59% |
